Usuari:Trollramsac/proves: diferència entre les revisions
Contingut suprimit Contingut afegit
Cap resum de modificació |
Cap resum de modificació |
||
Línia 93:
* [[Infecció cutània|Infeccions cutànies]]
* [[Infecció urinària|Infeccions urinàries]]
* [[Malaltia inflamatòria pelviana]]
* [[Sèpsia]] bacteriana
Línia 99:
* [[Sèpsia]] bacteriana
* Infeccions intraabdominals
* Profilaxi quirúrgica
* [[Malaltia de Lyme]]<ref name="AHFS2016" />
▲Ceftriaxone is also a choice drug for treatment of [[bacterial meningitis]] caused by [[pneumococci]], [[meningococci]], ''[[Haemophilus influenzae]]'', and "susceptible enteric Gram-negative rods, but not ''[[Listeria monocytogenes]]''."<ref name="Katzung 2009 783–7842">{{cite book|last = Katzung|first = Bertram|title = Basic and Clinical Pharmacology, Eleventh Edition|date = 2009|publisher = McGraw-Hill|location = New York|isbn = 978-0-07-160405-5|pages = 783–784}}</ref>
▲In combination with doxycycline or azithromycin, ceftriaxone is recommended by the United States [[Centers for Disease Control and Prevention]] (CDC) for the treatment of gonorrhea. By itself, it is not recommended due to the potential for resistance development.<ref>{{cite journal | title = Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections | journal = MMWR. Morbidity and Mortality Weekly Report | volume = 61 | issue = 31 | pages = 590–4 | date = August 2012 | pmid = 22874837 | doi = | url = https://www.cdc.gov/mmwr/pdf/wk/mm6131.pdf | author1 = Centers for Disease Control Prevention (CDC) }}</ref>
=== Espectre d'activitat ===
|